insights_auto
Why is ARX up 2.50%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
AU$0.49
arrow_upward
+2.50%(+0.012) 1D
ኖቬም 17, 4:00:00 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
AU$0.49
High
AU$0.50
Low
AU$0.48
Mkt. cap
170.18 ሚ
Avg. vol.
265.00 ሺ
Volume
313.07 ሺ
P/E ratio
46.95
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
Open
AU$0.49
High
AU$0.50
Low
AU$0.48
Mkt. cap
170.18 ሚ
Avg. vol.
265.00 ሺ
Volume
313.07 ሺ
P/E ratio
46.95
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
News stories
From web sources and news partners
ChartMill
·
ከ1 ሰዓት በፊት
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
·
ከ20 ደቂቃዎች በፊት
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
FOREX.com
·
ከ1 ሰዓት በፊት
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Traders Union
·
ከ37 ደቂቃዎች በፊት
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd